Abstract
Current algorithms for the serologic confirmation of human T-cell lymphotropic virus type I and II (HTLV-I/II) antibody reactivity are complicated. We evaluated the performance of an HTLV-I Western blot (immunoblot) spiked with recombinant p21e protein (p21e WB) as an alternative to current confirmatory methods. These methods include the HTLV-I viral lysate Western blot and either a radioimmunoprecipitation assay or a p21e enzyme-linked immunosorbent assay. Five hundred fifty nine blood donations obtained from five U.S. blood centers and classified as HTLV-I/II seropositive (n = 149) or seroindeterminate (n = 410) by routine testing methods were further evaluated by PCR for proviral DNA and by the p21e WB. On the basis of serologic and PCR testing, 155 donations were classified as HTLV-I/II infected. The sensitivity of the p21e WB was 97.4%, slightly exceeding that of routine confirmatory testing. The specificity of the p21e WB was 97.5%, as determined by testing of 404 seroindeterminate samples that were negative in the PCR. The positive predictive value of the p21e WB was 94%. In contrast, the specificity and positive predictive value of routine confirmatory testing were both 100%. Follow-up sampling of presumptive p21e WB false-positive donors substantiated the absence of HTLV-I/II infection. Although the p21e WB used in this study has high sensitivity and may be useful as a confirmatory assay in epidemiologic research studies, it may not be ideal as a confirmatory test for the notification of blood donors.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chou Q., Russell M., Birch D. E., Raymond J., Bloch W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res. 1992 Apr 11;20(7):1717–1723. doi: 10.1093/nar/20.7.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donegan E., Pell P., Lee H., Shaw G. M., Mosley J. W. Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. The Transfusion Safety Study Group. Transfusion. 1992 Jan;32(1):68–71. doi: 10.1046/j.1537-2995.1992.32192116436.x. [DOI] [PubMed] [Google Scholar]
- Hartley T. M., Khabbaz R. F., Cannon R. O., Kaplan J. E., Lairmore M. D. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol. 1990 Apr;28(4):646–650. doi: 10.1128/jcm.28.4.646-650.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartley T. M., Malone G. E., Khabbaz R. F., Lal R. B., Kaplan J. E. Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms. J Clin Microbiol. 1991 Jun;29(6):1125–1127. doi: 10.1128/jcm.29.6.1125-1127.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwok S., Kellogg D., Ehrlich G., Poiesz B., Bhagavati S., Sninsky J. J. Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis. 1988 Dec;158(6):1193–1197. doi: 10.1093/infdis/158.6.1193. [DOI] [PubMed] [Google Scholar]
- Lal R. B., Brodine S., Kazura J., Mbidde-Katonga E., Yanagihara R., Roberts C. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections. J Clin Microbiol. 1992 Feb;30(2):296–299. doi: 10.1128/jcm.30.2.296-299.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee H. H., Weiss S. H., Brown L. S., Mildvan D., Shorty V., Saravolatz L., Chu A., Ginzburg H. M., Markowitz N., Des Jarlais D. C. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis. 1990 Aug;162(2):347–352. doi: 10.1093/infdis/162.2.347. [DOI] [PubMed] [Google Scholar]
- Lillehoj E. P., Alexander S. S., Dubrule C. J., Wiktor S., Adams R., Tai C. C., Manns A., Blattner W. A. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide. J Clin Microbiol. 1990 Dec;28(12):2653–2658. doi: 10.1128/jcm.28.12.2653-2658.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manns A., Wilks R. J., Murphy E. L., Haynes G., Figueroa J. P., Barnett M., Hanchard B., Blattner W. A. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992 Jul 30;51(6):886–891. doi: 10.1002/ijc.2910510609. [DOI] [PubMed] [Google Scholar]
- Okochi K., Sato H., Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984;46(5):245–253. doi: 10.1111/j.1423-0410.1984.tb00083.x. [DOI] [PubMed] [Google Scholar]
- Roberts B. D., Foung S. K., Lipka J. J., Kaplan J. E., Hadlock K. G., Reyes G. R., Chan L., Heneine W., Khabbaz R. F. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II. J Clin Microbiol. 1993 Feb;31(2):260–264. doi: 10.1128/jcm.31.2.260-264.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sullivan M. T., Williams A. E., Fang C. T., Grandinetti T., Poiesz B. J., Ehrlich G. D. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group. Arch Intern Med. 1991 Oct;151(10):2043–2048. [PubMed] [Google Scholar]